Table 1 Components of the general synthetic index (SI): definition of each indicator of process and results[19]
Indicator | Description |
|---|---|
1 | Acceptable blood pressure control (<140/90 mm Hg, except in diabetes patients: <130/80 mm Hg. |
2 | Acceptable diabetes control, with a target of glycated haemoglobin (HbA1c) <7% |
3 | Blood pressure screening |
4 | Diabetes mellitus screening |
5 | Cardiovascular risk calculation in patients aged 35–74 years with total cholesterol >200 mg/dl |
6 | Alcohol consumption screening (adult population) |
7 | Ex-smokers, at one year |
8 | Ischemic heart disease patients with adequate antiplatelet treatment |
9 | Ischemic heart disease patients with low density lipoprotein <100 mg/ml |
10 | Cardiac arrhythmia patients with atrial fibrillation and anticoagulation treatment |
11 | Population >74 years attended and assigned, including home health care |
12 | Population >74 years attended and assigned, including home health care, with evaluation |
13 | Flu vaccine administered in the assigned population aged 60 years or more |
14 | Patients with chronic obstructive pulmonary disease and pneumococcal vaccine administered |
15 | Use of generic pharmaceutical specialties |
16 | Use of new medications with limited added value |
17 | Average cost per defined daily doses of proton pump inhibitors |
18 | Average cost per defined daily dose of statins |
19 | Average cost per defined daily dose of angiotensin-converting enzyme inhibitors (ACEI) and angiotensin II receptors antagonists (Angio II) |
20 | Average cost per defined daily dose of serotonin re-uptake inhibitors and new-generation antidepressants |